SCHEMBL10156591

SCHEMBL10156591

CN1CCN(c2ccc(N=O)cc2NS(C)(=O)=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
TSHR P16473 1/20 0.39
CYP3A4 P08684 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ERAP1 Q9NZ08 1/20 0.37
MTHFD2 P13995 4/20 0.36
HTR6 P50406 1/20 0.36
MTHFD1 P11586 3/20 0.36
HTT P42858 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10126898 0.81 KDM4E (0.54) ALDH1A1GAAHPGDMAPK1TSHR
SCHEMBL14355835 0.77 TSHR (0.52) ALDH1A1GAAMAPK1TSHRMEN1
SCHEMBL10126902 0.76 WDR5 (0.60) ALDH1A1GAACYP3A4CYP1A2CYP2C19
SCHEMBL10157809 0.76 LMNA (0.43) ALDH1A1GAACYP3A4KDM4EMEN1
SCHEMBL29037852 0.74 KDM4E (0.50) ALDH1A1KDM4ECYP1A2CYP2C19LMNA
SCHEMBL10156732 0.74 KDM4E (0.44) ALDH1A1GAAMAPK1KDM4EMEN1
SCHEMBL25735583 0.70 ALDH1A1 (0.45) ALDH1A1HPGDCYP3A4MEN1CYP1A2
SCHEMBL10157151 0.70 ALDH1A1 (0.45) ALDH1A1GAACYP3A4KDM4EMEN1
SCHEMBL10156805 0.69 CSNK1D (0.43) ALDH1A1MAPK1KDM4ECYP1A2CYP2C19
SCHEMBL22542115 0.69 HTR6 (0.47) ALDH1A1GAAHPGDMAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 ALDH1A1 1554/4885GAA 3821/4885HPGD 4520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.